Evidence map›Paper›PMID 27908981›Full record

ReviewClinical science (London, England : 1979)2017

Neurotrophin signalling: novel insights into mechanisms and pathophysiology.

Mariela Mitre, Abigail Mariga, Moses V Chao

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical science (London, England : 1979), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 2 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 2 syntheses or guidelines pooled it, 255 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Plasma BDNF levels in children with ADHD before and after methylphenidate treatment.Scandinavian journal of child and adolescent psychiatry and psychology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mariela MitreNeuroscience and Physiology and Psychiatry, New York University School of Medicine, New York, NY 10016, U.S.A. mariela.mitre@med.nyu.edu.
Abigail MarigaSkirball Institute for Biomolecular Medicine, New York University School of Medicine, New York, NY 10016, U.S.A.
Moses V ChaoNeuroscience and Physiology and Psychiatry, New York University School of Medicine, New York, NY 10016, U.S.A.
New York University · US

Funding

MOLECULAR BIOLOGY OF THE NERVE GROWTH FACTOR RECEPTORR01NS021072 · NINDS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CHAO, MOSES VICTOR · 1985 to 2015
$5.8M
Gamma-Secretase cleavage of the p75 receptorR01AG025970 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHAO, MOSES VICTOR · 2006 to 2016
$3.3M
Training Program in Molecular, Cellular, and Translational NeuroscienceT32NS086750 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JEREMY S DASEN, Katherine Nagel · 2014 to 2026
$2.4M
Molecular Analysis of Neurotrophin ActionR56NS021072 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHAO, MOSES VICTOR · 2011 to 2017
$882k
Regulation of BACE1 by trophic factor signalingR56AG025970 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHAO, MOSES VICTOR · 2018 to 2018
$494k
NIA NIH HHS R01 AG025970NIA NIH HHS R56 AG025970NINDS NIH HHS R01 NS021072NINDS NIH HHS R56 NS021072NINDS NIH HHS T32 NS086750
6 · The paper itself

Abstract

Neurotrophins, such as brain-derived neurotrophic factor (BDNF), are prominent regulators of neuronal survival, growth and differentiation during development. While trophic factors are viewed as well-understood but not innovative molecules, there are many lines of evidence indicating that BDNF plays an important role in the pathophysiology of many neurodegenerative disorders, depression, anxiety and other psychiatric disorders. In particular, lower levels of BDNF are associated with the aetiology of Alzheimer's and Huntington's diseases. A major challenge is to explain how neurotrophins are able to induce plasticity, improve learning and memory and prevent age-dependent cognitive decline through receptor signalling. This article will review the mechanism of action of neurotrophins and how BDNF/tropomyosin receptor kinase B (TrkB) receptor signaling can dictate trophic responses and change brain plasticity through activity-dependent stimulation. Alternative approaches for modulating BDNF/TrkB signalling to deliver relevant clinical outcomes in neurodegenerative and neuropsychiatric disorders will also be described.

Indexed as

Signal TransductionAnimalsBrainHumansNerve Growth FactorsNeurodegenerative DiseasesReceptors, Nerve Growth FactorNerve Growth FactorsReceptors, Nerve Growth Factoractivity-dependent expressiondeep brain stimulationneuroprotectionneurotrophinsignallingsynaptic plasticity

Identifiers

PMID27908981
PMCPMC5295469
OpenAlexW2557883205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.